Idenix Suits Target Gilead Hep C Drug Nearing Approval
Idenix Pharmaceuticals Inc. told two federal courts Sunday that Gilead Sciences Inc. is on course to infringe its intellectual property if the U.S. Food and Drug Administration approves Gilead's new drug...To view the full article, register now.
Already a subscriber? Click here to view full article